FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

2409111000001101: Half Sinemet CR 25mg/100mg tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1747561000001115 Half Sinemet CR 25mg/100mg tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1747571000001113 Half Sinemet CR 25mg/100mg tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
25194101000001117 Half Sinemet CR 25mg/100mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 60 tablet 6 x 10 tablets (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
25194201000001112 Half Sinemet CR 25mg/100mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 60 tablet 6 x 10 tablets en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
38053701000001114 Half Sinemet CR 25mg/100mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 60 tablet 6 x 10 tablets en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
55815101000001117 Half Sinemet CR 25mg/100mg tablets (Merck Sharp & Dohme Ltd) 60 tablet 6 x 10 tablets en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Half Sinemet CR 25mg/100mg tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Is a Co-careldopa 25mg/100mg modified-release tablets 60 tablet true Inferred relationship Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Is pack of Half Sinemet CR 25mg/100mg tablets (Organon Pharma (UK) Ltd) false Inferred relationship Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Has active ingredient Carbidopa false Inferred relationship Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Has active ingredient Levodopa false Inferred relationship Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Has AMP Half Sinemet CR 25mg/100mg tablets (Organon Pharma (UK) Ltd) true Inferred relationship Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Carbidopa true Inferred relationship Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Has specific active ingredient Levodopa true Inferred relationship Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Has specific active ingredient Carbidopa monohydrate false Inferred relationship Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Has specific active ingredient Carbidopa monohydrate true Inferred relationship Existential restriction modifier
Half Sinemet CR 25mg/100mg tablets (Organon Pharma (UK) Ltd) 60 tablet 6 x 10 tablets Has basis of strength substance Carbidopa true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start